
Navigating the Vascular Risks of Cancer Therapy: Balancing Cardiac Safety and Tumor Control
Published on Nov 21
3分钟
0:000:00
Guest: Jun-ichi Abe, MD, PhD <br>
<p data-end="951" data-start="398">Cancer therapies can trigger both acute and chronic vascular effects, from treatment-induced hypertension to long-term atherosclerotic changes. Learn more as Dr. Jun-ichi Abe shares insights from his presentation at the 2025 American Heart Association Scientific Sessions. Dr. Abe is a Professor in the Department of Cardiology at The University of Texas MD Anderson Cancer Center in Houston.</p>